Michael Gould to Dalteparin
This is a "connection" page, showing publications Michael Gould has written about Dalteparin.
Connection Strength
0.249
-
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial. Trials. 2014 Dec 20; 15:502.
Score: 0.125
-
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA. 2014 Nov 26; 312(20):2135-45.
Score: 0.124